Immunodeficiency 74 Covid 19 Related X Linked C5435745
An X-linked immunodeficiency that increases susceptibility to severe COVID-19. It primarily affects males and requires careful COVID-19 management and prevention strategies.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Immune thrombocytopenic purpura
Severe refractory COVID-19 infection
Generalized symptoms
(immunologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Recurrent upper respiratory tract infections
(respiratory)Persistent generalized fatigue
(general)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Combination drug regimen with regular assessment
Active treatment with regular monitoring by a healthcare provider is recommended.
COVID-19 Antiviral Therapy
Early antiviral treatment for COVID-19 infection using approved agents to reduce severity and complications. Prompt initiation at first positive test is critical in immunocompromised patients.
Monoclonal Antibody Therapy
COVID-19 specific monoclonal antibody preparations for treatment and post-exposure prophylaxis in this high-risk population. Selection based on variant susceptibility patterns.
Additional treatment options
Immunoglobulin Therapy
IVIG providing broad-spectrum antibody support and potential COVID-19 neutralizing antibodies. Regular maintenance dosing may provide some protection against severe COVID-19 outcomes.
medicationCOVID-19 Prevention Protocol
Rigorous avoidance strategies including masking, ventilation improvements, and social distancing. Education on rapid testing and early intervention protocols for patient and household contacts.
lifestyleRespiratory Function Monitoring
Regular pulmonary assessment including oximetry and imaging as indicated to detect early COVID-19 complications or long-term sequelae. Baseline and serial evaluation essential.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Immunodeficiency 74 Covid 19 Related X Linked C5435745?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Immunodeficiency 74 Covid 19 Related X Linked C5435745. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy